Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
2,136,077
Value
$67.1M
% of portfolio
0.1%
Quarters held
20
Since Q3 2021
Holdings of CPRX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,136,077$67.1M0.1%−211,400−9.0%ReducedHolders
Q1 20262,347,477$58.1M0.1%−302,600−11.4%ReducedHolders
Q4 20252,650,077$61.9M0.1%−894,753−25.2%ReducedHolders
Q3 20253,544,830$69.8M0.1%+293,314+9.0%AddedHolders
Q2 20253,251,516$70.6M0.1%+295,200+10.0%AddedHolders
Q1 20252,956,316$71.7M0.1%+250,200+9.2%AddedHolders
Q4 20242,706,116$56.5M0.1%+180,100+7.1%AddedHolders
Q3 20242,526,016$50.2M0.1%+350,289+16.1%AddedHolders
Q2 20242,175,727$33.7M0.1%+287,300+15.2%AddedHolders
Q1 20241,888,427$30.1M<0.1%+291,000+18.2%AddedHolders
Q4 20231,597,427$26.9M<0.1%+308,327+23.9%AddedHolders
Q3 20231,289,100$15.1M<0.1%+134,200+11.6%AddedHolders
Q2 20231,154,900$15.5M<0.1%+64,800+5.9%AddedHolders
Q1 20231,090,100$18.1M<0.1%−141,412−11.5%ReducedHolders
Q4 20221,231,512$22.9M<0.1%−995,000−44.7%ReducedHolders
Q3 20222,226,512$28.6M<0.1%+1,194,900+115.8%AddedHolders
Q2 20221,031,612$7.23M<0.1%+678,500+192.1%AddedHolders
Q1 2022353,112$2.93M<0.1%−69,774−16.5%ReducedHolders
Q4 2021422,886$2.86M<0.1%+370,648+709.5%AddedHolders
Q3 202152,238$277.0K<0.1%+52,238NewHolders